These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 10357499)

  • 21. Long-Term Survival, Quality of Life, and Quality-Adjusted Survival in Critically Ill Patients With Cancer.
    Normilio-Silva K; de Figueiredo AC; Pedroso-de-Lima AC; Tunes-da-Silva G; Nunes da Silva A; Delgado Dias Levites A; de-Simone AT; Lopes Safra P; Zancani R; Tonini PC; Vasconcelos de Andrade E Silva U; Buosi Silva T; Martins Giorgi J; Eluf-Neto J; Costa A; Abrahão Hajjar L; Biasi Cavalcanti A
    Crit Care Med; 2016 Jul; 44(7):1327-37. PubMed ID: 26998653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design of sequentially randomized trials for testing adaptive treatment strategies.
    Ogbagaber SB; Karp J; Wahed AS
    Stat Med; 2016 Mar; 35(6):840-58. PubMed ID: 26412033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychological, social and welfare interventions for psychological health and well-being of torture survivors.
    Patel N; Kellezi B; Williams AC
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD009317. PubMed ID: 25386846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term (10-year) outcome in patients with unstable angina pectoris treated by coronary balloon angioplasty.
    Halon DA; Flugelman MY; Merdler A; Rennert H; Shahla J; Lewis BS
    J Am Coll Cardiol; 1998 Nov; 32(6):1603-9. PubMed ID: 9822085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Five-year survival, quality of life, and individual costs of 303 consecutive medical intensive care patients--a cost-utility analysis.
    Graf J; Wagner J; Graf C; Koch KC; Janssens U
    Crit Care Med; 2005 Mar; 33(3):547-55. PubMed ID: 15753746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrating health profile with survival for quality of life assessment.
    Hwang JS; Wang JD
    Qual Life Res; 2004 Feb; 13(1):1-10; discussion 11-4. PubMed ID: 15058782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival 15 to 20 years after coronary bypass surgery for angina.
    Rahimtoola SH; Fessler CL; Grunkemeier GL; Starr A
    J Am Coll Cardiol; 1993 Jan; 21(1):151-7. PubMed ID: 8417057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin: systematic review and economic evaluation.
    Simpson EL; Duenas A; Holmes MW; Papaioannou D; Chilcott J
    Health Technol Assess; 2009 Mar; 13(17):iii, ix-x, 1-154. PubMed ID: 19331797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Years of healthy life--selected states, United States, 1993-1995.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 Jan; 47(1):5-7. PubMed ID: 9450722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of preoperative staging and chemoradiation versus postoperative chemoradiation on outcome in patients with rectal cancer: a decision analysis.
    Telford JJ; Saltzman JR; Kuntz KM; Syngal S
    J Natl Cancer Inst; 2004 Feb; 96(3):191-201. PubMed ID: 14759986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy: one-year results of the randomized TIME trial.
    Pfisterer M; Buser P; Osswald S; Allemann U; Amann W; Angehrn W; Eeckhout E; Erne P; Estlinbaum W; Kuster G; Moccetti T; Naegeli B; Rickenbacher P;
    JAMA; 2003 Mar; 289(9):1117-23. PubMed ID: 12622581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bias and precision of measures of survival gain from right-censored data.
    Lamb KE; Williamson EJ; Coory M; Carlin JB
    Pharm Stat; 2015; 14(5):409-17. PubMed ID: 26218830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using value of information methods to determine the optimal sample size for effectiveness trials of alcohol interventions for HIV-infected patients in East Africa.
    Li L; Uyei J; Nucifora KA; Kessler J; Stevens ER; Bryant K; Braithwaite RS
    BMC Health Serv Res; 2018 Jul; 18(1):590. PubMed ID: 30064428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methods for the economic and quality of life supplement to the cilostazol for RESTenosis (CREST) trial.
    Weintraub WS; Foster J; Culler SD; Becker ER; Parker K; Zhang Z; Kolm P; Douglas JS;
    J Invasive Cardiol; 2004 May; 16(5):257-9. PubMed ID: 15152132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and sample size estimation in clinical trials with clustered survival times as the primary endpoint.
    Xie T; Waksman J
    Stat Med; 2003 Sep; 22(18):2835-46. PubMed ID: 12953283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sample size and power estimation for studies with health related quality of life outcomes: a comparison of four methods using the SF-36.
    Walters SJ
    Health Qual Life Outcomes; 2004 May; 2():26. PubMed ID: 15161494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy of trimetazidine on stable angina pectoris: a meta-analysis of randomized clinical trials.
    Peng S; Zhao M; Wan J; Fang Q; Fang D; Li K
    Int J Cardiol; 2014 Dec; 177(3):780-5. PubMed ID: 25466565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sample sizes for clinical trials with time-to-event endpoints and competing risks.
    Schulgen G; Olschewski M; Krane V; Wanner C; Ruf G; Schumacher M
    Contemp Clin Trials; 2005 Jun; 26(3):386-96. PubMed ID: 15911472
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.